The physiological impact of proinsulin C-peptide

Pathophysiology

Volumn 5, Issue 4, 1999, Pages 257-262

  Kunt, Thomas ^a   Forst, Thomas ^a   Pfützner, Andreas ^a   Beyer, Jürgen ^a   Wahren, John ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C peptide; eNOS; Insulin; Na+,K+ ATPase; Proinsulin

Indexed keywords

C PEPTIDE; NITRIC OXIDE SYNTHASE;

BLOOD FLOW; DOSE RESPONSE; ENDOTHELIUM CELL; HORMONE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0345369694     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(98)00028-5     Document Type: Article

References (64)

1. Steiner D.F., Oyen P.E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc. Natl. Acad. Sci. USA. 57:1967;473-480.
2. Steiner D.F., Cunningham D., Spigelman L., Aten B. Insulin biosynthesis: evidence for a precursor. Science. 157:1967;679-700.
3. Chan S.J., Keim P., Steiner D.F. Cell-free synthesis of rat preproinsulins: characterization and partial amino acid sequence determination. Proc. Natl. Acad. Sci. USA. 73:1964;1976.
4. Harper M.E., Ullrich A., Saunders G.F. Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc. Natl. Acad. Sci. USA. 78:1981;4458-4460.
5. Lomedico P., Rosenthal N., Efstratidadis A., Gilbert W., Kolodner R., Tizard R. The structure and evolution of the non-allelic rat preproinsulin genes. Cell. 18:1979;545-558.
6. Bell G.I., Pictet R.L., Rutter W.J., Cordell B., Tischer E., Goodman H.M. Sequence of the human insulin gene. Nature. 284:1980;26-32.
7. Steiner D.F. On the role of proinsulin C-peptide. Diabetes. 27(Suppl. 1):1978;145-148.
8. Smeekens S.P., Montag A.G., Thomas G. et al. Proinsulin processing by the subtilisin-related proprotein convertases furin PC2 and PC3. Proc. Natl. Acad. Sci. USA. 89:1992;8822-8826.
9. Kwok S.C., Chan S.J., Steiner D.F. Cloning and nucleotide sequence analysis of the dog insulin gene. J. Biol. Chem. 258:1983;2357-2363.
10. Gieseg M.A., Swarbrick P.A., Perko L., Powell R.J., Cutfield J.F. Elephant fish proinsulin possesses a monobasic processing site. Gen. Comp. Endocrinol. 108:1997;199-208.
11. Michael J., Carroll R., Swift H.H., Steiner D.F. Studies on the molecular organization of rat secretory granules. J. Biol. Chem. 262:1987;16531-16535.
12. Wei G., Hu M.H., Tang J.G. Double C-peptide human proinsulin. Biochem. Mol. Biol. Int. 35:1995;37-46.
13. D. Brandenburg, H.G. Gattner, W. Schermutzki, in: M. Friedhelm (Ed.), Protein Crosslinking, part A 1987, Plenum Press, New York, 1977, pp. 261-282.
14. Kaarsholm N.C., Ko H.C., Dunn M.F. Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin and miniproinsulin. Biochemistry. 28:1989;4427-4435.
15. Gutman R.A., Lazarus N.R., Recant L. Electrophoretic characterization of circulating human proinsulin and insulin. Diabetologia. 8:1972;136-140.
16. Faber O.K., Hagen C., Binder C. et al. Kinetics of human connecting peptide in normal and diabetic subjects. J. Clin. Invest. 62:1978;197-203.
17. Horwitz D.L., Starr J.I., Rubenstein A.H., Steiner D.F. Serum connecting peptide-an indicator of beta cell secretory function. Diabetes. 22(Suppl. 1):1973;298.
18. Sjöberg S., Johansson B.L., Östman J., Wahren J. Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;423-428.
19. Stoll R.W., Touber J.L., Menahan L.A., Williams R.H. Clearance of porcine insulin, proinsulin, and connecting peptide by the isolated rat liver. Proc. Soc. Exp. Biol. Med. 133:1970;894-896.
20. Conlon J.M., Höög A., Grimelius L. Intracellular degradation of the C-peptide of proinsulin in a human insulinoma: identification of sites of cleavage and evidence for a role for cathepsin B. Pancreas. 10:1995;167-172.
21. Verchere C.B., Paoletta M., Neerman-Arbez M. et al. Des (27-31) C-peptide: a novel secretory product of the rat pancreatic beta cell produced by truncation of proinsulin connecting peptide in secretory granules. J. Biol. Chem. 271:1996;27475-27481.
22. Garcia M.J., Mc Namara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes. 23:1974;105-111.
23. King G.L., Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol. Metab. Clin. North Am. 25:1996;255-270.
24. The DCCT research group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977-986.
25. Madsbad S. Prevalence of residual β-cell function and its metabolic consequences in type 1 (insulin-dependent) diabetics. Diabetologia. 24:1983;141-147.
26. Sjöberg S., Gunnarsson R., Gjötterberg M., Persson A., Östman J. Residual insulin production, glycemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 30:1987;208-213.
27. Kobbah A.M., Ewald U., Tuvemo T. Impaired vascular reactivity during the first two years of diabetes mellitus after initial restoration. Diabetes Res. 8:1988;101-109.
28. Kernell A., Ludvigsson J., Finnström K. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and C-peptide levels. Acta Ophthalmol. 68:1990;415-420.
29. Yu S.S., Kitabchi A.E. Biological activity of proinsulin and related polypeptides in the fat tissue. J. Biol. Chem. 248:1973;3753-3761.
30. Kitabchi A.E. The biological and immunological properties of pork and beef insulin proinsulin and connecting peptides. J. Clin. Invest. 49:1970;979-987.
31. Solomon S.S., Brush J.S., Kitabchi A.E. Antilipolytic activity of insulin and proinsulin on ACTH and cyclic nucleotide-induced lipolysis in the isolated adipose cell of rat. Biochim. Biophys. Acta. 218:1970;167-169.
32. Kitabchi A.E. Proinsulin and C-Peptide: a review. Metabolism. 26:1977;547-587.
33. C. Wojcikowski, R.D. Fussgänger, E.F. Pfeiffer, Inhibition of insulin and glucagon secretion of the isolated perfused rat pancreas by synthetic human and rat C-Peptide, in: J. Beyer, U. Krause, W. Naegele (Eds.), Proceedings of the first International Symposium on C-Peptide, Mainz, Schnetzor-Verlag, Konstanz, 1977, pp. 75-94.
34. Toyota T., Abe K., Kudo M., Kimura K., Goto Y. Inhibitory effects of synthetic rat C-peptide I on insulin secretion in isolated perfused rat pancreas. Tohuku J. Exp. Med. 117:1975;79-83.
35. Wojcikowski C., Maier V., Dominak K., Fussgänger R., Pfeiffer E.F. Effect of synthetic rat C-peptide in normal and diabetic rats. Diabetologia. 25:1983;288-290.
36. Hoogwerf B.J., Bantle J.P., Gaenslen H.E. et al. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism. 35:1986;122-125.
37. Hagen C., Faber O.K., Binder C., Alberti K.G. Lack of metabolic effects of C-peptide in normal subjects and juvenile diabetic patients. Acta Endocrinol. 85(Suppl. 209):1977;29A.
38. Flatt P.R., Swanston-Flatt S.K., Hampton S.M., Bailey C.J., Marks V. Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumour. Biosci. Reports. 6:1986;196-199.
39. Johansson B.L., Sjöberg S., Wahren J. The influence of human C-peptide on renal function and glucose utilisation in type 1 (insulin dependent) diabetic patients. Diabetologia. 35:1992;121-128.
40. Johansson B.L., Linde B., Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia. 35:1992;1151-1158.
41. Zierath J.R., Galuska D., Johansson B.L., Wallberg-Henriksson H. Effect of human C-peptide on glucose transport in in vitro incubated skeletal muscle. Diabetologia. 34:1991;899-901.
42. Zierath J.R., Thörne A., Johansson B.L., Wallberg-Henriksson H. C-peptide stimulates glucose transport in type 1 diabetic skeletal muscle. Diabetologia. 33:1990;226.
43. Zierath J.R., Handberg A., Tally M., Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia. 39:1996;306-313.
44. Johansson B.L., Kernell A., Sjöberg S., Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J. Clin. Endocr. Metab. 77:1993;976-981.
45. Johansson B.L., Fernqvist-Forbes E., Wahren J. Effects of C-peptide on nephropathy and neuropathy in IDDM-patients-a clinical study. Diabetologia. 38:1995;7.
46. L.J. Melton, P.J. Dyck, Epidemiology, in: P.J. Dyck, P.K. Thomas, A.K. Asbury, A.I. Winegard, J.R. Porte (Eds.), Diabetic Neuropathy, Philadelphia, W.B. Saunders, 1987, pp. 27-35.
47. Ewing D.J., Clarke B.F. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care. 9:1986;648-665.
48. P.K. Thomas, Diabetic neuropathy: epidemiology and pathogenesis, in: J.C. Pickup, G. Williams (Eds.), Textbook of Diabetes, Vol. 2, Oxford, Blackwell, 1991, pp. 613-622.
49. Johansson B.L., Borg K., Fernqvist-Forbes E., Odergren T., Remahl S., Wahren J. C-peptide improves autonomic nerve function in patients with type 1 diabetes. Diabetologia. 39:1996;687-695.
50. Ido Y., Vindigni A., Chang K. et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 277:1997;563-566.
51. Lindström K., Johansson C., Johnsson E., Haraldsson B. Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat. Acta Physiol. Scand. 156:1996;19-25.
52. Forst T., Kunt T., Pohlmann T. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 101:1998;2036-2041.
53. Kunt T., Forst T., Lehmann R. Human C-peptide increases calcum influx into endothelial cells. Diabetes. 47(Suppl 1):1998;30.
54. T. Kunt, S. Schneider, A. Pfützner, The effect of human proinsulin C-peptide on erythrocyte deformability in type 1 diabetes patients, Diabetologia (submitted for publication).
55. Leclerq-Meyer V., Malaisse E.J., Johansson B.L., Wahren J. Effect of C-peptide on insulin and glucagon release by isolated perfused rat pancreas. Diabetes Metabol. 23:1997;149-154.
56. Cohen P., Barzilai N., Karnieli E. Suppression of insulin secretion by C-peptide infusion in humans. Isr. J. Med. Sci. 31:1995;284-288.
57. + pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat. Diabetes. 36:1987;842-848.
58. +-ATPase activity and ist αII subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism. 41:1992;56-63.
59. +-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am. J. Physiol. 265:1993;E96-E101.
60. +-ATPase activity in synergism with neuropeptide Y. Diabetologia. 39:1996;199-205.
61. +-ATPase activity in streptozotocin diabetic rats, C-peptide and type I diabetes mellitus, Stockholm, Karolinska Institute, Symposium, September 1994, pp. 23-24.
62. +-ATPase activity: a negative feedback mechanism in insulin secretion? Diabetologia. 39(Suppl 1):1996;71.
63. +-ATPase activity of renal tubule segments. Diabetologia. 41:1998;287-291.
64. Schlesinger P.H., Ido Y., Williamson J.R. Conductive channel properties of human C-peptide incorporated into planar lipid bilayers. Diabetes. 47(Suppl 1):1998;29.